Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Dual Strategy to Design New Agents Targeting Schistosoma mansoni: Advancing Phenotypic and SmCB1 Inhibitors for Improved Efficacy.

ACS infectious diseases - 10 May 2024

Fuchs Natalie, Zimmermann Robert A, Schwickert Marvin, Gunkel Annika, Zimmer Collin, Meta Mergim, Schwickert Kevin, Keiser Jennifer, Haeberli Cécile, Kiefer Werner, Schirmeister Tanja

Abstract excerpt

In this study, we have identified and optimized two lead structures from an in-house screening, with promising results against the parasitic flatworm Schistosoma mansoni and its target protease S. mansoni cathepsin B1 (SmCB1). Our correlation analysis highlighted the significance of physicochemical properties for the compounds' in vitro activities, resulting in a dual approach to optimize the lead structures,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anthelmintics
Share to Cathepsin B

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Design

Share to Helminth Proteins

Share to Phenotype

Share to Schistosoma mansoni

Share to Schistosomiasis mansoni

Share to Structure-Activity Relationship

Source

Identifiers

PMID: 38686397
DOI: 10.1021/acsinfecdis.4c00020

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Dual Strategy to Design New Agents Targeting Schistosoma mansoni: Advancing Phenotypic and SmCB1 Inhibitors for Improved Efficacy.PMID 38686397Read ↗

Structural and Functional Characterization of Schistosoma mansoni Cathepsin B1.Semantic proximity Read ↗

Screening and Phenotypical Characterization of Schistosoma mansoni Histone Deacetylase 8 (SmHDAC8) Inhibitors as Multistage Antischistosomal Agents.Semantic proximity Read ↗

Structure-Reactivity Relationships on Substrates and Inhibitors of the Lysine Deacylase Sirtuin 2 from Schistosoma Mansoni (SmSirt2)Semantic proximity Read ↗

Identification of 6-(piperazin-1-yl)-1,3,5-triazine as a chemical scaffold with broad anti-schistosomal activitiesSemantic proximity Read ↗

A genome-scale drug discovery pipeline uncovers therapeutic targets and a unique p97 allosteric binding site in Schistosoma mansoniSemantic proximity Read ↗

A genome-scale drug discovery pipeline uncovers new therapeutic targets and a unique p97 allosteric binding site in <i>Schistosoma mansoni</i>Semantic proximity Read ↗

Drugging the Schistosome Zinc-Dependent HDACs: Current Progress and Future PerspectivesSemantic proximity Read ↗

Rational approach to drug discovery for human schistosomiasisSemantic proximity Read ↗

HDAC8: a multifaceted target for therapeutic interventions.Semantic proximity Read ↗

<i>Schistosoma mansoni</i> lysine specific demethylase 1 (SmLSD1) is a druggable target involved in parasite survival, oviposition and stem cell proliferationSemantic proximity Read ↗

Proteins as Targets in Anti-Schistosomal Drug Discovery and Vaccine DevelopmentSemantic proximity Read ↗

Chemical modulation of Schistosoma mansoni lysine specific demethylase 1 (SmLSD1) induces wide-scale biological and epigenomic changesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.